Polycaprolactone: Difference between revisions
Jump to navigation
Jump to search
(Minor Text Formatting Fix) |
(Added some more information) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 7: | Line 7: | ||
=External Links= | =External Links= | ||
*[https://en.wikipedia.org/wiki/Polycaprolactone The Wikipedia Page on Polycaprolactone] | *[https://en.wikipedia.org/wiki/Polycaprolactone The Wikipedia Page on Polycaprolactone] | ||
* https://www.frontiersin.org/articles/10.3389/fcell.2021.629796/full#:~:text=Polycaprolactone%20(PCL)%2C%20which%20is,et%20al.%2C%202020). | *[https://www.frontiersin.org/articles/10.3389/fcell.2021.629796/full#:~:text=Polycaprolactone%20(PCL)%2C%20which%20is,et%20al.%2C%202020). A 2021 Paper Titled "3D Printed Biomimetic PCL Scaffold as Framework Interspersed With Collagen for Long Segment Tracheal Replacement" ] "Polycaprolactone (PCL), which is approved by the United States Food and Drug Administration (FDA) for internal use in the human body, is the most widely used 3D-printable biomaterial (Li et al., 2020)" | ||
[[Category: Bio-Petrochemistry]] [[Category: Plastics]] | [[Category: Bio-Petrochemistry]] [[Category: Plastics]] | ||
Latest revision as of 23:55, 31 December 2021
Basics
- Most common 3D-printable biomaterial
Internal Links
External Links
- The Wikipedia Page on Polycaprolactone
- A 2021 Paper Titled "3D Printed Biomimetic PCL Scaffold as Framework Interspersed With Collagen for Long Segment Tracheal Replacement" "Polycaprolactone (PCL), which is approved by the United States Food and Drug Administration (FDA) for internal use in the human body, is the most widely used 3D-printable biomaterial (Li et al., 2020)"